"N Engl J Med"[journal] 检索结果

21. Copy-Number Variation and False Positive Results of Prenatal Screening.

作者: Yatika Jivan.;Betsy Peach.;Colm Keane.
来源: N Engl J Med. 2015年373卷26期2584-5页

22. Copy-Number Variation and False Positive Results of Prenatal Screening.

作者: Dirk van den Boom.;Mathias Ehrich.;Sung K Kim.
来源: N Engl J Med. 2015年373卷26期2584页

23. Copy-Number Variation and False Positive Results of Prenatal Screening.

作者: Christopher Kingsley.;Eric Wang.;Arnold Oliphant.
来源: N Engl J Med. 2015年373卷26期2583页

24. Copy-Number Variation and False Positive Results of Prenatal Screening.

作者: Matthew W Snyder.;Hilary S Gammill.;Jay Shendure.
来源: N Engl J Med. 2015年373卷26期2585页

25. Cell-free DNA Analysis for Noninvasive Examination of Trisomy.

作者: Loïc Sentilhes.;Laurent J Salomon.;Christophe Vayssière.
来源: N Engl J Med. 2015年373卷26期2581-2页

26. Cell-free DNA Analysis for Noninvasive Examination of Trisomy.

作者: Rebecca Smith-Bindman.;Diana Miglioretti.
来源: N Engl J Med. 2015年373卷26期2581页

27. Cell-free DNA Analysis for Noninvasive Examination of Trisomy.

作者: Mary E Norton.;Ronald J Wapner.
来源: N Engl J Med. 2015年373卷26期2582页

28. Telomerase Inhibitor Imetelstat in Essential Thrombocythemia and Myelofibrosis.

作者: Mads E Bjørn.;Claus H Nielsen.;Hans C Hasselbalch.
来源: N Engl J Med. 2015年373卷26期2579-80页

29. Telomerase Inhibitor Imetelstat in Essential Thrombocythemia and Myelofibrosis.

作者: Daniel El Fassi.
来源: N Engl J Med. 2015年373卷26期2579页

30. Telomerase Inhibitor Imetelstat in Essential Thrombocythemia and Myelofibrosis.

作者: Gabriela M Baerlocher.;Bart Burington.;David S Snyder.
来源: N Engl J Med. 2015年373卷26期2580页

31. Environmental Microbial Exposure and Protection against Asthma.

作者: Patrick G Holt.;Peter D Sly.
来源: N Engl J Med. 2015年373卷26期2576-8页

32. Treatment for Chlamydia Infection--Doxycycline versus Azithromycin.

作者: Thomas C Quinn.;Charlotte A Gaydos.
来源: N Engl J Med. 2015年373卷26期2573-5页

33. Second Cancers after Treatment for Hodgkin's Lymphoma--Continuing Cause for Concern.

作者: John Radford.;Dan L Longo.
来源: N Engl J Med. 2015年373卷26期2572-3页

34. CASE RECORDS of the MASSACHUSETTS GENERAL HOSPITAL. Case 40-2015. A 40-Year-Old Homeless Woman with Headache, Hypertension, and Psychosis.

作者: Derri L Shtasel.;Oliver Freudenreich.;Travis P Baggett.
来源: N Engl J Med. 2015年373卷26期2563-70页

35. IMAGES IN CLINICAL MEDICINE. Polychondritis with Auricular and Ocular Involvement.

作者: Gabriela Rodríguez-Colón.;Alan G Palestine.
来源: N Engl J Med. 2015年373卷26期2562页

36. Comfort Care for Patients Dying in the Hospital.

作者: Craig D Blinderman.;J Andrew Billings.
来源: N Engl J Med. 2015年373卷26期2549-61页

37. Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis.

作者: Dominique Baeten.;Joachim Sieper.;Jürgen Braun.;Xenofon Baraliakos.;Maxime Dougados.;Paul Emery.;Atul Deodhar.;Brian Porter.;Ruvie Martin.;Mats Andersson.;Shephard Mpofu.;Hanno B Richards.; .; .
来源: N Engl J Med. 2015年373卷26期2534-48页

Secukinumab is an anti-interleukin-17A monoclonal antibody that has been shown to control the symptoms of ankylosing spondylitis in a phase 2 trial. We conducted two phase 3 trials of secukinumab in patients with active ankylosing spondylitis.

38. Selexipag for the Treatment of Pulmonary Arterial Hypertension.

作者: Olivier Sitbon.;Richard Channick.;Kelly M Chin.;Aline Frey.;Sean Gaine.;Nazzareno Galiè.;Hossein-Ardeschir Ghofrani.;Marius M Hoeper.;Irene M Lang.;Ralph Preiss.;Lewis J Rubin.;Lilla Di Scala.;Victor Tapson.;Igor Adzerikho.;Jinming Liu.;Olga Moiseeva.;Xiaofeng Zeng.;Gérald Simonneau.;Vallerie V McLaughlin.; .
来源: N Engl J Med. 2015年373卷26期2522-33页

In a phase 2 trial, selexipag, an oral selective IP prostacyclin-receptor agonist, was shown to be beneficial in the treatment of pulmonary arterial hypertension.

39. Azithromycin versus Doxycycline for Urogenital Chlamydia trachomatis Infection.

作者: William M Geisler.;Apurva Uniyal.;Jeannette Y Lee.;Shelly Y Lensing.;Shacondra Johnson.;Raymond C W Perry.;Carmel M Kadrnka.;Peter R Kerndt.
来源: N Engl J Med. 2015年373卷26期2512-21页

Urogenital Chlamydia trachomatis infection remains prevalent and causes substantial reproductive morbidity. Recent studies have raised concern about the efficacy of azithromycin for the treatment of chlamydia infection.

40. Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma.

作者: Michael Schaapveld.;Berthe M P Aleman.;Anna M van Eggermond.;Cécile P M Janus.;Augustinus D G Krol.;Richard W M van der Maazen.;Judith Roesink.;John M M Raemaekers.;Jan Paul de Boer.;Josée M Zijlstra.;Gustaaf W van Imhoff.;Eefke J Petersen.;Philip M P Poortmans.;Max Beijert.;Marnix L Lybeert.;Ina Mulder.;Otto Visser.;Marieke W J Louwman.;Inge M Krul.;Pieternella J Lugtenburg.;Flora E van Leeuwen.
来源: N Engl J Med. 2015年373卷26期2499-511页

Survivors of Hodgkin's lymphoma are at increased risk for treatment-related subsequent malignant neoplasms. The effect of less toxic treatments, introduced in the late 1980s, on the long-term risk of a second cancer remains unknown.

结果排序

文献格式

出版时间

出版类型

出版语言